Clinical Assistant Professor of Pediatrics
Service Chief, Pediatrics
Medical Director of Non-Oncology Infusion
[email protected]
Available to mentor
Smriti Mohan
Clinical Assistant Professor
-
Beukelman T, Tomlinson G, Nigrovic PA, Dennos A, Del Gaizo V, Jelinek M, Riordan ME, Schanberg LE, Mohan S, Pfeifer E, Kimura Y, CARRA FROST Investigators . Pediatr Rheumatol Online J, 2022 Dec 8; 20 (1): 113Journal ArticleFirst-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
DOI:10.1186/s12969-022-00768-6 PMID: 36482434 -
Michniacki TF, Walkovich K, DeMeyer L, Saad N, Hannibal M, Basiaga ML, Horst KK, Mohan S, Chen L, Brodeur K, Du Y, Frame D, Ngo S, Simoneau J, Brown N, Lee PY. J Clin Immunol, 2022 Nov; 42 (8): 1766 - 1777.Journal ArticleSOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition.
DOI:10.1007/s10875-022-01346-x PMID: 35976468 -
2019 Jan 1;Presentation"Rheumatologic Management of Juvenile Idiopathic Arthritis and Uveitis"
-
Mor-Vaknin N, Rivas M, Legendre M, Mohan S, Yuanfan Y, Mau T, Johnson A, Huang B, Zhao L, Kimura Y, Spalding SJ, Morris PW, Gottlieb BS, Onel K, Olson JC, Edelheit BS, Shishov M, Jung LK, Cassidy EA, Prahalad S, Passo MH, Beukelman T, Mehta J, Giannini EH, Adams BS, Lovell DJ, Markovitz DM. Arthritis Rheumatol, 2018 Apr; 70 (4): 594 - 605.Journal ArticleHigh Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.
DOI:10.1002/art.40404 PMID: 29287303 -
Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, Koch AE, Fox DA, Engelke DR, Kaplan MJ, Markovitz DM. Nat Commun, 2017 Feb 6; 8: 14252Journal ArticleDEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.
DOI:10.1038/ncomms14252 PMID: 28165452 -
Mohan S, Barsalou J, Bradley TJ, Slorach C, Reynolds JA, Hasni S, Thompson B, Ng L, Levy D, Silverman E, Kaplan MJ. Arthritis Rheumatol, 2015 May; 67 (8): 2257 - 2262.Journal ArticleEndothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus.
DOI:10.1002/art.39149 PMID: 25891295 -
2012 Nov 1;Presentation"Raising a Child with Arthritis: What to Expect, What's New and Managing Family Dynamics"
-
Mohan S, Mor-Vaknin N, Legendre M, Adams BS, Markovitz DM. 2014 Jan 1;Proceeding / Abstract / PosterCitrullination as a Post-translational Modification of the Human DEK Protein May Not Enhance Immunogenicity in Juvenile Idiopathic Arthritis.
